UNLABELLED: "Extended" (multiple-flow) measurements of exhaled nitric oxide (FeNO) potentially can distinguish proximal and distal airway inflammation, but have not been evaluated previously in large populations. We performed extended NO testing within a longitudinal study of a school-based population, to relate bronchial flux (J'awNO) and peripheral NO concentration (CalvNO) estimates with respiratory health status determined from questionnaires. We measured FeNO at 30, 50, 100, and 300 ml/sec in 1,640 subjects aged 12-15 from eight communities, then estimated J'awNO and CalvNO from linear and nonlinear regressions of NO output versus flow. J'awNO, as well as FeNO at all flows, showed influences of asthma, allergy, Asian or African ancestry, age, and height (positive), and of weight (negative), generally corroborating past findings. By contrast, CalvNO results were inconsistent across different extended NO regression models, and appeared more sensitive to small measurement artifacts. CONCLUSIONS: Extended NO testing is feasible in field surveys of young populations. In interpreting results, size, age, and ethnicity require attention, as well as instrumental and environmental artifacts. J'awNO and conventional FeNO provide similar information, probably reflecting proximal airway inflammation. CalvNO may give additional information relevant to peripheral airway, alveolar, or systemic pathology. However, it needs additional research, including testing of populations with independently verifiable peripheral or systemic pathology, to optimize measurement technique and interpretation.
UNLABELLED: "Extended" (multiple-flow) measurements of exhaled nitric oxide (FeNO) potentially can distinguish proximal and distal airway inflammation, but have not been evaluated previously in large populations. We performed extended NO testing within a longitudinal study of a school-based population, to relate bronchial flux (J'awNO) and peripheral NO concentration (CalvNO) estimates with respiratory health status determined from questionnaires. We measured FeNO at 30, 50, 100, and 300 ml/sec in 1,640 subjects aged 12-15 from eight communities, then estimated J'awNO and CalvNO from linear and nonlinear regressions of NO output versus flow. J'awNO, as well as FeNO at all flows, showed influences of asthma, allergy, Asian or African ancestry, age, and height (positive), and of weight (negative), generally corroborating past findings. By contrast, CalvNO results were inconsistent across different extended NO regression models, and appeared more sensitive to small measurement artifacts. CONCLUSIONS: Extended NO testing is feasible in field surveys of young populations. In interpreting results, size, age, and ethnicity require attention, as well as instrumental and environmental artifacts. J'awNO and conventional FeNO provide similar information, probably reflecting proximal airway inflammation. CalvNO may give additional information relevant to peripheral airway, alveolar, or systemic pathology. However, it needs additional research, including testing of populations with independently verifiable peripheral or systemic pathology, to optimize measurement technique and interpretation.
Authors: Emmanouil Paraskakis; Caterina Brindicci; Louise Fleming; Renata Krol; Sergei A Kharitonov; Nicola M Wilson; Peter J Barnes; Andrew Bush Journal: Am J Respir Crit Care Med Date: 2006-04-20 Impact factor: 21.405
Authors: Sylvia Verbanck; Andrei Malinovschi; Steven George; Arthur F Gelb; Walter Vincken; Alain Van Muylem Journal: Eur Respir J Date: 2012-05 Impact factor: 16.671
Authors: G W K Wong; E K H Liu; T F Leung; E Yung; F W S Ko; D S C Hui; T F Fok; C K W Lai Journal: Clin Exp Allergy Date: 2005-07 Impact factor: 5.018
Authors: Muhammad T Salam; Hyang-Min Byun; Fred Lurmann; Carrie V Breton; Xinhui Wang; Sandrah P Eckel; Frank D Gilliland Journal: J Allergy Clin Immunol Date: 2011-11-04 Impact factor: 10.793
Authors: Peter J Barnes; Raed A Dweik; Arthur F Gelb; Peter G Gibson; Steven C George; Hartmut Grasemann; Ian D Pavord; Felix Ratjen; Philip E Silkoff; D Robin Taylor; Noe Zamel Journal: Chest Date: 2010-09 Impact factor: 9.410
Authors: William S Linn; Edward B Rappaport; Kiros T Berhane; Tracy M Bastain; Muhammad T Salam; Frank D Gilliland Journal: Pediatr Pulmonol Date: 2009-10
Authors: James L Puckett; Richard W E Taylor; Szu-Yun Leu; Olga L Guijon; Anna S Aledia; Stanley P Galant; Steven C George Journal: Respir Res Date: 2010-04-28
Authors: Sandrah P Eckel; William S Linn; Muhammad T Salam; Theresa M Bastain; Yue Zhang; Edward B Rappaport; Meng Liu; Kiros Berhane Journal: J Asthma Date: 2014-08-28 Impact factor: 2.515
Authors: Sandrah P Eckel; William S Linn; Kiros Berhane; Edward B Rappaport; Muhammad T Salam; Yue Zhang; Frank D Gilliland Journal: PLoS One Date: 2014-01-17 Impact factor: 3.240
Authors: Sandrah P Eckel; Zilu Zhang; Rima Habre; Edward B Rappaport; William S Linn; Kiros Berhane; Yue Zhang; Theresa M Bastain; Frank D Gilliland Journal: Eur Respir J Date: 2016-01-21 Impact factor: 16.671
Authors: Alan Lunt; Na'eem Ahmed; Gerrard F Rafferty; Moira Dick; David Rees; Sue Height; Swee Lay Thein; Anne Greenough Journal: Pediatr Res Date: 2015-10-22 Impact factor: 3.756
Authors: Olaia Sardón; Paula Corcuera; Ane Aldasoro; Javier Korta; Javier Mintegui; José I Emparanza; Eduardo G Pérez-Yarza Journal: BMC Pulm Med Date: 2014-08-04 Impact factor: 3.317